文献速递脑血管病神经重症与神经感染

中介分析揭示INTERACT3脑出血集束化治疗中各组分对功能结局的独立效应

Mediation Analysis to Identify Individual Component Effects of the Care Bundle to Improve Functional Outcome After ICH in the INTERACT3 Study.
PubMed 文献 · Neurology · 2025-09-12

该研究基于INTERACT3阶梯楔形整群随机对照试验,对6225例急性脑出血患者进行因果中介分析,评估集束化治疗各组分对6个月mRS改善的贡献。结果显示仅血压和血糖控制对获益有正向贡献,达到收缩压和血糖目标的中介比例分别为4.0%和7.6%,实际24小时收缩压和血糖水平的中介比例分别为8.9%和7.0%。

要点

  • 集束化治疗中仅收缩压和血糖控制对功能获益有正向中介贡献。
  • 达到收缩压和血糖目标的中介比例分别为4.0%和7.6%。
  • 实际24小时收缩压和血糖水平的中介比例分别为8.9%和7.0%。

核心结论

  • INTERACT3集束化治疗改善急性脑出血功能结局的主要贡献来自收缩压和血糖控制,表现为实际达标水平和方案目标达成均起中介作用。

研究设计与样本

  • 基于INTERACT3阶梯楔形整群随机对照试验,纳入6225例有6个月mRS数据的急性脑出血患者进行基于模型的因果中介分析。

主要发现

  • 仅血压和血糖控制对集束化治疗的获益有正向贡献,实际24小时收缩压和血糖的中介比例分别为8.9%(95%CI 4.8-20.0)和7.0%(1.1-17.0)。
  • 达到收缩压和血糖指定目标的中介比例分别为4.0%(95%CI 1.2-14.0)和7.6%(2.2-15.0)。

临床怎么用

  • 在急性脑出血集束化治疗中应优先落实收缩压和血糖控制,以最大化功能获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial (INTERACT3) showed that the implementation of a care bundle improves the functional outcome of patients who experience acute intracerebral hemorrhage (ICH). However, uncertainty exists over the relative contribution of each component of the care bundle for the benefit. METHODS: INTERACT3 used a stepped-wedge, cluster randomized controlled trial design, which was conducted in 5 lower and 4 upper middle-income countries and 1 high-income country. Compared with usual care, there was a statistically significant beneficial effect of the intervention, a care bundle comprising early control of elevated blood pressure (BP), glucose, and temperature and reversal of warfarin-related anticoagulation, on the primary outcome of functional recovery of ICH. We performed a model-based causal mediation analysis to assess the contribution of each component of the care bundle to the overall effect, as measured by the modified Rankin Scale (mRS) at 6 months after randomization. The mediation analysis considered whether protocol-specified treatment targets were reached as well as the actual achieved levels of physiologic control according to the summary measures of systolic BP (mean, variation over 1-24 hours, and reduction in 1 hour) and mean of blood glucose, body temperature, and international normalized ratio over 24 hours. The analyses were performed in the modified intention-to-treat population with available mRS data. RESULTS: A total of 6,225 patients (mean age 61.9 years [SD 12.6], 2,284 women [36.5%]) with available primary outcome data were included in these analyses. Overall, only the control of BP and blood glucose contributed positively to the beneficial effect, with mediated proportions of 8.9% (95% CI 4.8-20.0) and 7.0% (1.1-17.0) for achieved systolic BP and blood glucose over 24 hours after randomization, respectively, and 4.0% (1.2-14.0) and 7.6% (2.2-15.0) for reaching the specified targets for systolic BP and blood glucose, respectively. DISCUSSION: The major contributors to the effectiveness of the care bundle in INTERACT3 for improved functional outcomes after acute ICH were the control of systolic BP and blood glucose, as indicated by both the achieved levels and protocol targets being met. TRIAL REGISTRATION INFORMATION: The name of the registry is "the Third, Intensive Care Bundle With Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial (INTERACT3)." This trial was submitted for registration at ClinicalTrials.gov (NCT03209258) on July 1, 2017, and the Chinese Clinical Trial Registry (ChiCTR-IOC-17011787) on June 28, 2017. The first patient was enrolled on December 12, 2017.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Ren X, Li Q, Ouyang M, et al. Mediation Analysis to Identify Individual Component Effects of the Care Bundle to Improve Functional Outcome After ICH in the INTERACT3 Study. Neurology. 2025. PMID: 40939125. doi:10.1212/WNL.0000000000214070

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。